Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
Wall Street Worries FDA Cuts Will Slow Drug Approvals
Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.
FDA broadens use of Novartis’ radiopharma drug Pluvicto
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
FDA's top vaccine official forced out, decries RFK Jr.'s "misinformation and lies"
A Department of Health and Human Services official delivered an ultimatum to Dr. Peter Marks: either resign or be fired.
STAT10h
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Top vaccine official Peter Marks is forced out of FDA
Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, was given the choice to resign or be ...
Top vaccine official Peter Marks forced out at FDA, WSJ reports
The U.S. Food and Drug Administration's top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal ...
FDA’s Top Vaccine Official Forced Out
In his resignation letter, Dr. Peter Marks cited “misinformation and lies” from Health and Human Services Secretary RFK Jr.
BioPharma Dive15h
FDA approves first-of-its-kind RNA drug for hemophilia
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
Top FDA Vaccine Official Resigns, Calls Out RFK Jr.’s ‘Misinformation and Lies’
Dr. Peter Marks, a top official at the Food and Drug Administration who helped lead the U.S. effort to rapidly develop ...
The top FDA vaccine official is forced out, cites RFK Jr.'s 'misinformation and lies'
A top vaccine advisor at the FDA was forced to resign on Friday. In his resignation letter, Dr. Peter Marks wrote "truth and transparency are not desired," by HHS Secretary Robert F. Kennedy Jr.
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...